Eagle Pharmaceuticals

$55.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.30 (-3.95%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell EGRX and other stocks, options, ETFs, and crypto commission-free!

About EGRX

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. Read More The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Employees
96
Headquarters
Woodcliff Lake, New Jersey
Founded
2007
Market Cap
865.27M
Price-Earnings Ratio
20.35
Dividend Yield
0.00
Average Volume
140.44K
High Today
$58.58
Low Today
$55.63
Open Price
$58.42
Volume
139.46K
52 Week High
$82.33
52 Week Low
$36.03

Collections

EGRX News

ReutersAug 11

Edited Transcript of EGRX earnings conference call or presentation 8-Aug-19 12:30pm GMT

1

EGRX Earnings

$0.53
$0.75
$0.98
$1.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market

More EGRX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.